News
Akston Biosciences and LakePharma Enter Covid-19 Partnership
Akston Biosciences, which develops new classes of biologic therapeutics, and LakePharma, a U.S.-based CRDMO serving the biotechnology community with development and production services, have...
Drug Research
INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact
INOVIO, a biotechnology company focused on precisely designed DNA medicines to treat and prevent infectious diseases and cancer, and Advaccine Biopharmaceuticals Suzhou, an emerging...
Clinical Trials
Bharat Biotech vaccine approved in clinical trial mode, consent of participants has to be taken: ICMR
Balram Bhargava, chief of Indian Council of Medical Research (ICMR), said on Tuesday that Bharat Biotech’s Covid-19 vaccine has been cleared in the clinical...
News
Chemo Drug Potentially More Potent than Remdesivir Against Coronavirus
Researchers with Shenzhen Institutes of Advanced Technology in China used a variety of computational techniques to simulate drug-virus interactions. They then screened 1,906 existing...
News
Covid 19: An opportunity in disguise for E-Pharmacies in India
Apex industry body, Federation of Indian Chambers of Commerce & Industry (FICCI) has forecasted that the e-pharmacies in India will grow rapidly and cater...
Drug Research
Incyte and Cellenkos Enter into Global Development Collaboration Agreement for CK0804
Incyte and Cellenkos, Inc., a privately held, clinical stage biotech company, announced a development collaboration to investigate the combination of ruxolitinib (Jakafi®) and CK0804,...
Clinical Trials
Tiziana Life Sciences completes clinical trial of nasally administered Foralumab to treat COVID-19 in Brazil
Tiziana Life Sciences announced the completion of its clinical study in Brazil investigating nasally administered Foralumab, its proprietary human monoclonal antibody, either alone or...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read